Shelbye Rose(omonas) retweeted
Don’t worry if this week has been hectic - we’ve got you covered with these must-read papers 📖☕️
#ACCPIDPRN
Shelbye Rose(omonas) retweeted
‼️Just shared at #IDWeek2025, our findings are now published in @OFIDJournal comparing cephalexin to cefdinir for uUTI in females. Spoiler: cefdinir was the only independent risk factor associated with/failure. Poor urinary PK = ⬆️failure. Let’s stop Rx’ing cefdinir for UTI! 🛑💊
🆕💫 Retrospective, multicenter cohort study(N: 367)
Cefdinir was independently associated with treatment failure with nearly twice as high of failure rate compared with cephalexin for the treatment of outpatient uncomplicated UTI #IDXposts #UTIWiki academic.oup.com/ofid/articl…
Shelbye Rose(omonas) retweeted
Please RT! Exciting opportunities in plant–microbe interactions!
My lab @IPMBSinica is looking for passionate postdocs & RAs to join us in one of the following areas:
✨ Cell death & immune signaling
🧬 Discovery of resistance genes
🧫 Development of Agrobacterium-based tools
Shelbye Rose(omonas) retweeted
🔥🔥Just published 🔥🔥
ATS CAP guidelines 2025
Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
Free access pdf @atscommunity
Thanks @Inox94 #IDXposts
atsjournals.org/doi/10.1164/…
Shelbye Rose(omonas) retweeted
Join the ACCP ID PRN for Acing That Interview – tips for navigating residency, fellowship, or job interviews.🤝
Date: 9/4 | Time: 4–5 PM EST | Virtual 💻
Refer to ID PRN listserv email 📩to register and Zoom link.
Shelbye Rose(omonas) retweeted
Congrats to Dr. Stephen Berger for being selected as an ACCP ID PRN Member Spotlight for Winter/Spring 2025! 🤩
Dr. Berger has been in practice for over 26 years & was one of the first pharmacists to gain BCIDP certification! Ty for your dedication to ID pharmacy 💊
#IDXPosts
!!
📢ACCP ID PRN is now accepting nominations for 2025-2026 officer positions (Chair-Elect and Secretary/Treasurer) 🗳️
Nominate a colleague or yourself today - nominations are due May 14th!
Please refer to your 📧 for more information
#IDXposts
100
Shelbye Rose(omonas) retweeted
Looking to level up your ID & HIV knowledge? 📚🤓
We've got you covered! Join us for this month's ACCP ID PRN Journal Club where we will discuss optimal mgmt for invasive Candida infections & DoxyPEP!
📅: Fri May 9th @ 12pm CT on Zoom
Check your 📧 for login details! #IDXposts
Shelbye Rose(omonas) retweeted
New study: Identifying Factors for Bloodstream Infections in Neonates in NICU #antibiotics in 1st week of life is a RF @inspired2leadQH @ABpreservation @AngelaD_ZA contagionlive.com/view/ident… via @contagionlive
Shelbye Rose(omonas) retweeted
Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other regimens in people with HIV starting therapy with AIDS-defining conditions. Results from the CORIS Cohort: The ACTUAS II Study.
✅ Just Accepted
bit.ly/4lskDTA
Shelbye Rose(omonas) retweeted
Don’t miss this! ‼️ To celebrate ID Pharmacists Day hosted by @SIDPharm, please enter the “Share your Story” contest by 4/25. SIDP wants to hear your ideas or projects that have advanced the field of ID pharmacy 💊🦠🧫
🔗: sidp.org/IDPharmacistsDay
#IDPharmacistsDay #IDXposts
Shelbye Rose(omonas) retweeted
🔍 Missed key updates in infectious diseases? Drs. Zahra Kassamali Escobar & Jamie L. Wagner have you covered at #MADID2025! 📢
Register now! 👉 mad-idmembership.vfairs.com/ 🗓️
@jwagsIDPharmD @zkePharmD @SIDPharm @accpinfdprn @SHEA_Epi
Shelbye Rose(omonas) retweeted
🚀 Learn from Dr. Wagner at #MADID2025 about ways to enhance efficiency of antimicrobial stewardship programs and explore interprofessional team dynamics! 💊✨
Register today! mad-idmembership.vfairs.com/ 🗓️
@jwagsIDPharmD @SIDPharm @SHEA_Epi @accpinfdprn
Shelbye Rose(omonas) retweeted
Registration is open for #MADID2025!
📅 See the exciting agenda here: mad-id.org/agenda
✅ Registration: mad-idmembership.vfairs.com/
👩🏫 Abstracts and 💰 Travel Grants: mad-idmembership.vfairs.com/…
@SIDPharm @SHEA_Epi @accpinfdprn @Contagion_Live
Shelbye Rose(omonas) retweeted
Effectiveness of ampicillin/sulbactam versus ceftriaxone for the initial treatment of community-acquired pneumonia in older adults: a target trial emulation study
✅ Just Accepted
✍️ @bizarreID
bit.ly/3R7PoPP
Shelbye Rose(omonas) retweeted
Another study contributing to the growing body of evidence highlighting the importance of antimicrobial stewardship at the time of hospital discharge 🫶🤩 #IDX
Antimicrobial stewardship initiative on prescribing at discharge from a community medical center bit.ly/3DFcCJU
Shelbye Rose(omonas) retweeted
ID PRN and SIDP members 📣📣 Are you or your team presenting at at ESCMID Global or the SHEA Spring Meeting this year?! If so, fill out this quick survey by Tues, April 1 so we can recognize your accomplishments and show off your hard work ‼️🔬🧪 #IDX
docs.google.com/forms/d/e/1F…
Shelbye Rose(omonas) retweeted
🔔 New Article!
Need to know about #measles?… here is an article I prepared for #pharmacists who want some cliff notes
👀 idstewardship.com/five-thing…
#TwitteRx #IDtwitter #IDxPosts




























